Clinical Trials

Search for trials
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 50
  • Start Date: June 11, 2020
A Multicenter Randomized Open-label Trial Comparing the Efficacy and Safety of Infliximab Versus Cyclophosphamide in Subjects With Idiopathic Refractory Scleritis
Clinical Trial
  • Status: Active, not recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 5
  • Start Date: April 4, 2019
Tofacitinib for the Treatment of Inflammatory Eye Disease
Search for trials
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 30
  • Start Date: January 1, 2019
An Open Label, Multi-centered, Randomized Phase 2 Study to Evaluate the Safety, Tolerability and Bioactivity of Subcutaneous ACTH GeL in PAtients With Scleritis: The ATLAS Study
Clinical Trial
  • Status: Recruiting
  • Participants: 650
  • Start Date: July 26, 2016
Uveitis/Intraocular Inflammatory Disease Biobank (iBank)
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Other
  • Participants: 160
  • Start Date: May 2016
Exploring Immune Cell Signatures in Autoimmunity and Ocular Surface Stress
Showing 1-5 of 5